Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fruman

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Current Topics in Microbiology and Immunology|June 22, 2010
Regulatory subunits of class IA PI3KDavid A Fruman
Current Opinion in Immunology|May 12, 2004
Phosphoinositide 3-kinase and its targets in B-cell and T-cell signalingDavid A Fruman
Cancer Cell|June 14, 2011
A lipid kinase cousin cooperates to promote cancerBrandon Beagle, David A Fruman
Immunological Reviews|March 18, 2009
Fine tuning the immune response with PI3KDavid A Fruman, Georges Bismuth
The Biochemical Journal|February 28, 2012
PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advancesLomon So, David A Fruman
Cancer Discovery|May 16, 2012
PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinicDavid A Fruman, Christian Rommel
Nature Reviews. Drug Discovery|February 1, 2014
PI3K and cancer: lessons, challenges and opportunitiesDavid A Fruman, Christian Rommel
Trends in Immunology|July 16, 2003
Regulation of quiescence in lymphocytesIsharat Yusuf, David A Fruman
Trends in Cancer|December 28, 2020
Targeting the Mevalonate Pathway in CancerDennis Juarez, David A Fruman
Trends in Pharmacological Sciences|August 8, 2023
The road less traveled: activating an oncogenic kinaseMadhuri Paul, David A Fruman
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Current Topics in Microbiology and Immunology|June 22, 2010
Regulatory subunits of class IA PI3KDavid A Fruman
Current Opinion in Immunology|May 12, 2004
Phosphoinositide 3-kinase and its targets in B-cell and T-cell signalingDavid A Fruman
Cancer Cell|June 14, 2011
A lipid kinase cousin cooperates to promote cancerBrandon Beagle, David A Fruman
Immunological Reviews|March 18, 2009
Fine tuning the immune response with PI3KDavid A Fruman, Georges Bismuth
The Biochemical Journal|February 28, 2012
PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advancesLomon So, David A Fruman
Cancer Discovery|May 16, 2012
PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinicDavid A Fruman, Christian Rommel
Nature Reviews. Drug Discovery|February 1, 2014
PI3K and cancer: lessons, challenges and opportunitiesDavid A Fruman, Christian Rommel
Trends in Immunology|July 16, 2003
Regulation of quiescence in lymphocytesIsharat Yusuf, David A Fruman
Trends in Cancer|December 28, 2020
Targeting the Mevalonate Pathway in CancerDennis Juarez, David A Fruman
Trends in Pharmacological Sciences|August 8, 2023
The road less traveled: activating an oncogenic kinaseMadhuri Paul, David A Fruman
Pageof 11